Revolution Medicines Inc (NAS:RVMDW)
$ 0.5382 -0.0718 (-11.77%) Market Cap: - Enterprise Value: - PE Ratio: 9,999.00 PB Ratio: 0 GF Score: 41/100

Q2 2024 Revolution Medicines Inc Earnings Call Transcript

Aug 07, 2024 / 08:30PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Revolution Medicines Q2 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Ryan Asay, Senior Vice President of Corporate Affairs. Please go ahead.

Ryan Asay
Revolution Medicines Inc - Senior Vice President, Corporate Affairs

Thank you, and welcome, everyone to the second-quarter 2024 earnings call. Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicines' Chairman and Chief Executive Officer; and Jack Anders, our Chief Financial Officer; Dr. Steve Kelsey, our President of R&D; and Dr. Wei Lin, our Chief Medical Officer, will join us for the Q&A portion of today's call.

I'll note that certain statements we make during this call will be forward looking. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot